Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses - PubMed (original) (raw)
Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses
Yusuke Kitazawa et al. Transplantation. 2007.
Abstract
Background: Immune regulatory CD4+CD25+ T (regulatory T; Treg) cells play a vital role in the induction and maintenance of self-tolerance. They are essential for the homeostasis of T cells, the prevention of autoimmunity, and the induction of tolerance to allogeneic donor grafts. However, the underlying mechanism of their functions remains mostly elusive. Therefore, we investigated here a crucial role of Treg cells in their response to alloantigen via the programmed death (PD)-1/PD-1 ligand (PD-L1) pathway.
Methods: In vitro mixed lymphocyte reaction (MLR) assay, graft-versus-host disease (GvHD) and a skin transplantation model were used to evaluate the mechanisms of PD-1/PD-L1 pathway.
Results: Blockade of the PD-1/PD-L1 pathway using anti-PD-L1 monoclonal antibodies (mAb) is found to inhibit Treg cell's ability to suppress and restore CD4+CD25-T-cell proliferation in vitro. GvHD was lethal after adoptive transfer of allogeneic C57BL/6 (H-2K) spleen cells to NOD/SCID (H-2K) mice unless CD25+ T cells were also included. Strikingly, the suppression of GvHD by CD25+ cells was abrogated by anti-PD-L1 mAb administration. The abrogation of Treg-cell-mediated suppression could also be demonstrated in a Balb/c (H-2K) to B6/Rag-2KO (H-2K) skin-allograft model.
Conclusions: The blockade of the PD-1/PD-L1 pathway abrogates Treg-mediated immunoregulation, thus suggesting that the PD-1/PD-L1 pathway is required for Treg suppression of the alloreactive responses of CD4+CD25-T cells. This finding has important implications for clarifying the mechanisms of allograft rejection and GvHD.
Similar articles
- Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X. He F, et al. Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19. Surgery. 2009. PMID: 19486771 - Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L, Han R, Hancock WW. Wang L, et al. Eur J Immunol. 2007 Oct;37(10):2983-90. doi: 10.1002/eji.200737583. Eur J Immunol. 2007. PMID: 17899549 - Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A, Noble A. Giorgini A, et al. J Leukoc Biol. 2007 Nov;82(5):1053-61. doi: 10.1189/jlb.0407227. Epub 2007 Aug 7. J Leukoc Biol. 2007. PMID: 17684039 - Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM, Tran G, Hodgkinson SJ. Hall BM, et al. Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29. Int Immunopharmacol. 2009. PMID: 19539571 Review. - Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD. Hess AD. Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):13-21. doi: 10.1016/j.bbmt.2005.11.002. Biol Blood Marrow Transplant. 2006. PMID: 16399597 Review.
Cited by
- Association of programmed cell death 1 (PD-1) gene polymorphism (rs10204525) with COVID-19 severity and mortality: A case-control study in the Iranian population.
Mirsharif ES, Rostamian A, Salehi M, Askari N, Ghazanfari T. Mirsharif ES, et al. Int Immunopharmacol. 2023 Jun;119:110114. doi: 10.1016/j.intimp.2023.110114. Epub 2023 Mar 31. Int Immunopharmacol. 2023. PMID: 37172423 Free PMC article. - Developmentally distinct CD4+ Treg lineages shape the CD8+ T cell response to acute Listeria infection.
Dolina JS, Lee J, Moore EL, Hope JL, Gracias DT, Matsutani T, Chawla A, Greenbaum JA, Linden J, Schoenberger SP. Dolina JS, et al. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2113329119. doi: 10.1073/pnas.2113329119. Epub 2022 Mar 3. Proc Natl Acad Sci U S A. 2022. PMID: 35239442 Free PMC article. - PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells.
Mazerolles F, Rieux-Laucat F. Mazerolles F, et al. PLoS One. 2021 Nov 18;16(11):e0260206. doi: 10.1371/journal.pone.0260206. eCollection 2021. PLoS One. 2021. PMID: 34793567 Free PMC article. - Regulatory T Cells as an Escape Mechanism to the Immune Response in Taenia crassiceps Infection.
Adalid-Peralta L, Lopez-Roblero A, Camacho-Vázquez C, Nájera-Ocampo M, Guevara-Salinas A, Ruiz-Monroy N, Melo-Salas M, Morales-Ruiz V, López-Recinos D, Ortiz-Hernández E, Demengeot J, Vazquez-Perez JA, Arce-Sillas A, Gomez-Fuentes S, Parkhouse RME, Fragoso G, Sciutto E, Sevilla-Reyes EE. Adalid-Peralta L, et al. Front Cell Infect Microbiol. 2021 Apr 13;11:630583. doi: 10.3389/fcimb.2021.630583. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33928043 Free PMC article. - Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.
Relecom A, Merhi M, Inchakalody V, Uddin S, Rinchai D, Bedognetti D, Dermime S. Relecom A, et al. J Exp Clin Cancer Res. 2021 Feb 18;40(1):74. doi: 10.1186/s13046-021-01872-3. J Exp Clin Cancer Res. 2021. PMID: 33602280 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials